Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
2.55T | 2.35T | 2.24T | 1.92T | 1.62T | 1.53T | Gross Profit |
511.99B | 497.43B | 413.32B | 404.37B | 366.42B | 332.12B | EBIT |
170.28B | 163.11B | 116.50B | 172.75B | 161.60B | 110.58B | EBITDA |
308.80B | 356.38B | 209.44B | 280.62B | 258.40B | 127.64B | Net Income Common Stockholders |
114.82B | 125.39B | 44.96B | 135.76B | 121.94B | 58.46B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
254.62B | 217.00B | 186.10B | 201.59B | 222.50B | 206.99B | Total Assets |
3.44T | 3.17T | 2.87T | 2.68T | 2.26T | 2.12T | Total Debt |
664.83B | 186.08B | 705.35B | 595.71B | 531.47B | 599.95B | Net Debt |
410.21B | -30.92B | 519.25B | 396.06B | 311.95B | 392.96B | Total Liabilities |
1.62T | 1.50T | 1.50T | 1.36T | 1.14T | 1.15T | Stockholders Equity |
1.79T | 1.64T | 1.35T | 1.29T | 1.10T | 947.29B |
Cash Flow | Free Cash Flow | ||||
177.68B | 193.05B | -10.25B | -20.23B | 119.23B | 24.51B | Operating Cash Flow |
297.22B | 321.49B | 143.49B | 94.99B | 219.16B | 168.05B | Investing Cash Flow |
-135.67B | -153.55B | -167.72B | -116.75B | -115.16B | -318.66B | Financing Cash Flow |
-147.33B | -181.56B | -16.46B | -60.24B | -121.60B | 135.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $20.65B | 16.36 | 9.86% | 0.99% | 5.35% | 23.87% | |
77 Outperform | $14.81B | 23.26 | 18.59% | 1.04% | -0.42% | 3.23% | |
73 Outperform | $38.46B | 28.22 | 14.97% | 0.69% | 5.22% | 4.46% | |
73 Outperform | $13.60B | 28.40 | 20.28% | 1.28% | -0.40% | -2.50% | |
72 Outperform | $13.07B | 26.12 | 13.77% | 1.59% | -0.16% | -15.42% | |
67 Neutral | $28.09B | 30.93 | 26.22% | 2.06% | -11.28% | -23.69% | |
63 Neutral | $4.27B | 11.40 | 5.38% | 214.63% | 4.11% | -8.98% |